findmyKOL
Clinical trialNCT04539002CompletedPhase 1/PHASE2Interventional

Aerobic Exercise for Remyelination in Multiple Sclerosis

SponsorOregon Health and Science UniversityEnrollment60Autoimmune Diseases of the Nervous SystemDemyelinating Autoimmune Diseases, CNSDemyelinating DiseasesExerciseMultiple SclerosisNervous System Diseases+1 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Oregon Health & Science University

    Portland, Oregon, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Apr 2021
Primary completion
27 Mar 2025
Completion
27 Mar 2025
Last update posted
31 Jul 2025
Registered enrollment
60
Registry id
NCT04539002

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.